• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过单倍型分析发现 BRCA1/BRCA2 种系变异。

Discovery of BRCA1/BRCA2 founder variants by haplotype analysis.

机构信息

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 1 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.

出版信息

Cancer Genet. 2022 Aug;266-267:19-27. doi: 10.1016/j.cancergen.2022.05.042. Epub 2022 May 28.

DOI:10.1016/j.cancergen.2022.05.042
PMID:35671604
Abstract

A significant number of hereditary breast or ovarian cancers are caused by germline variants, mostly BRCA1/BRCA2 genes. Because genetic predispositions vary by ethnicity, several studies have reported founder variants of BRCA1/BRCA2 genes. Such founder variants were reported primarily based on their relevant population frequencies. We reviewed the variant data relating to BRCA1 and BRCA2 genes from January 2012 to March 2019 at Samsung Medical Center, Seoul, Korea. Among the cases with pathogenic variants (PVs) or likely pathogenic variants (LPVs), we defined recurrent variants as those found in more than five unrelated patients. Using single nucleotide polymorphisms, we analyzed patient haplotypes. There were 14 recurrent variants in the BRCA1 gene and seven variants in the BRCA2 gene. Of note, three variants in each gene were primarily detected in Korean populations. Among them, the c.5339T>C (p.Leu1780Pro) BRCA1 variant had a long block sized 74.5 kb. In BRCA2, the c.1399A>T (p.Lys467*) variant had a long block sized 35.5 kb. We suggest that BRCA1 c.5339T>C (p.Leu1780Pro) and BRCA2 c.1399A>T (p.Lys467*) are founder variants of the Korean population. These two recurrent variants were ethnicity-prevalent, primarily found in Korean populations, and the sizes of the linkage disequilibrium blocks are longer than others.

摘要

大量遗传性乳腺癌或卵巢癌是由种系变异引起的,主要是 BRCA1/BRCA2 基因。由于遗传易感性因种族而异,因此有几项研究报告了 BRCA1/BRCA2 基因的创始变体。这些创始变体主要是根据其相关人群频率报告的。我们回顾了 2012 年 1 月至 2019 年 3 月在韩国首尔三星医疗中心与 BRCA1 和 BRCA2 基因相关的变异数据。在具有致病性变异(PVs)或可能致病性变异(LPVs)的病例中,我们将反复出现的变异定义为在五个以上无亲缘关系的患者中发现的变异。我们使用单核苷酸多态性分析了患者的单倍型。BRCA1 基因中有 14 个反复出现的变异,BRCA2 基因中有 7 个变异。值得注意的是,每个基因中的三个变异主要在韩国人群中检测到。其中,BRCA1 基因的 c.5339T>C(p.Leu1780Pro)变异有一个 74.5kb 的长块。在 BRCA2 中,c.1399A>T(p.Lys467*)变异有一个 35.5kb 的长块。我们建议 BRCA1 c.5339T>C(p.Leu1780Pro)和 BRCA2 c.1399A>T(p.Lys467*)是韩国人群的创始变体。这两个反复出现的变异是种族流行的,主要在韩国人群中发现,并且连锁不平衡块的大小大于其他变异。

相似文献

1
Discovery of BRCA1/BRCA2 founder variants by haplotype analysis.通过单倍型分析发现 BRCA1/BRCA2 种系变异。
Cancer Genet. 2022 Aug;266-267:19-27. doi: 10.1016/j.cancergen.2022.05.042. Epub 2022 May 28.
2
Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.中国家族性乳腺癌/卵巢癌女性中BRCA1和BRCA2基因的新型种系突变及未分类变异
BMC Cancer. 2016 Feb 6;16:64. doi: 10.1186/s12885-016-2107-6.
3
Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.北非乳腺癌和卵巢癌中 BRCA 基因的特定和复发/起始致病性变异的流行率。
BMC Cancer. 2022 Feb 25;22(1):208. doi: 10.1186/s12885-022-09181-4.
4
BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.BRCA1 c.5470_5477del,中国汉族乳腺癌患者中的一个 founder 突变。
Int J Cancer. 2020 Jun 1;146(11):3044-3052. doi: 10.1002/ijc.32877. Epub 2020 Feb 22.
5
Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.比较 40 岁以下被诊断患有乳腺癌的澳大利亚女性中 BRCA1 和 BRCA2 致病性突变携带者与非携带者常见遗传变异和单倍型的频率。
BMC Cancer. 2010 Sep 1;10:466. doi: 10.1186/1471-2407-10-466.
6
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.中国大陆家族性乳腺癌和卵巢癌患者中BRCA种系变异的患病率及谱系
Oncotarget. 2016 Feb 23;7(8):9600-12. doi: 10.18632/oncotarget.7144.
7
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.克里特岛分离人群中的 BRCA1 和 BRCA2 种系检测揭示了新的和强烈的遗传起源效应。
Int J Cancer. 2020 Sep 1;147(5):1334-1342. doi: 10.1002/ijc.32903. Epub 2020 Mar 5.
8
Genetic testing in Poland and Ukraine: should comprehensive germline testing of and be recommended for women with breast and ovarian cancer?波兰和乌克兰的基因检测:是否应推荐对乳腺癌和卵巢癌女性进行全面胚系检测?
Genet Res (Camb). 2020 Aug 10;102:e6. doi: 10.1017/S0016672320000075.
9
Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients.韩国乳腺癌患者中BRCA1和BRCA2基因变异双重杂合性的临床病理特征
Cancer Res Treat. 2022 Jul;54(3):827-833. doi: 10.4143/crt.2021.791. Epub 2021 Oct 13.
10
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.

引用本文的文献

1
Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients.尼日利亚乳腺癌患者种系BRCA1和BRCA2变异的筛查
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251333012. doi: 10.1177/15330338251333012. Epub 2025 Apr 11.
2
Navigating the genetic landscape of breast cancer in South Africa amidst a developing healthcare system.在南非发展中的医疗体系背景下探索乳腺癌的基因图谱。
Front Genet. 2024 Jan 8;14:1330946. doi: 10.3389/fgene.2023.1330946. eCollection 2023.
3
BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review.
三发性异时性恶性肿瘤中的BRCA2、PALB2、RECQL4种系致病性变异及体细胞TP53突变:一例报告及文献综述
Int Med Case Rep J. 2024 Jan 10;17:23-29. doi: 10.2147/IMCRJ.S440132. eCollection 2024.
4
Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond.发现意义:RAD51 调节因子 BRCA2 及其他蛋白的变异分类的新视角。
DNA Repair (Amst). 2023 Oct;130:103563. doi: 10.1016/j.dnarep.2023.103563. Epub 2023 Aug 19.